Abiopharma

Clinical trial NCT07490860: start date: 2026-08-01 → 2026-09-01.

Clinical trial NCT06787612 updates: 1. completion date: 2028-10-30 → 2028-06-30 2. primary completion date: 2028-10-30 → 2028-06-30 3. enrollment: 220 → 297 participants

Clinical trial NCT06313593 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 186 → 37 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06659640 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 120 → 89 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07728708: start date: 2026-09-01 → 2026-10-01.

Clinical trial NCT06162663 updates: 1. primary completion date: 2026-02-17 → 2026-01-15 2. enrollment: 5 → 6 participants

Clinical trial NCT06693531 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 350 → 368 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06360289 updates: 1. completion date: 2027-12-01 → 2027-12-15 2. primary completion date: 2027-12-01 → 2027-12-15

Clinical trial NCT05272709 updates: 1. completion date: 2027-06-01 → 2028-04-01 2. primary completion date: 2027-06-01 → 2028-04-01 3. enrollment: 188 → 60 participants

Clinical trial NCT06969170 updates: 1. start date: 2025-05-06 → 2025-05-16 2. completion date: 2026-08-30 → 2028-12-30 3. primary completion date: 2026-06-01 → 2027-12-31